Fiona Walter

Direct to Patient Testing at Cancer Diagnosis for Precision Prevention-2 (DETECT-2): protocol for a two-arm equivalence UK multi-centre randomised controlled trial evaluating uptake of genetic testing

Caitlin T. Fierheller, Priyanka Deshmukh, Ashwin Kalra, Hamda Mohamed et autres

Background Mainstreaming ovarian, endometrial, and colorectal cancer patients, in the context of genetic-testing at cancer diagnosis, involves pre-test counselling, consent, and return of results by the clinical cancer team, which uses significant clinician time and resources. Alternative implementation strategies might be more …

gb, us (code pays fourni par la source)

AI11 Explainable multiclass artificial intelligence for safe identification and subtyping of benign skin lesions in suspected cancer pathways

Chayabhan Limpabandhu, Farzad Shams, Zeeshaan-U I Hasan, Zion Tse et autres

Abstract Urgent skin cancer referral pathways in the UK are characterized by very high volumes of benign disease. Many referrals arise from benign lesions that raise clinical concern for malignancy, reflecting diagnostic uncertainty in primary care and placing avoidable pressure on dermatology …

gb (code pays fourni par la source)

Protocol for the DETECT-2 randomised controlled trial: a comparison of direct-to-patient versus mainstreaming genetic testing at ovarian, endometrial and colorectal cancer diagnosis

Caitlin T. Fierheller, Priyanka Deshmukh, Ashwin Kalra, Hamda Mohamed et autres

gb (code pays fourni par la source)